JPM24: Bluebird CEO points to ‘very innovative contract’ to defend Lyfgenia’s pricing premium over CRISPR rival aliu Wed, 01/10/2024 – 18:28 More: JPM24: Bluebird CEO points to 'very innovative contract' to defend Lyfgenia's pricing premium over CRISPR rival Source: fierce
read moreJPM24: Riding label expansions and launches, AZ plots course toward ‘industry-leading growth’ by 2030 zbecker Wed, 01/10/2024 – 12:18 More: JPM24: Riding label expansions and launches, AZ plots course toward 'industry-leading growth' by 2030 Source: fierce
read moreJPM24: In booming obesity field, Novo Nordisk is ‘just getting going,’ CEO says fkansteiner Wed, 01/10/2024 – 11:18 More: JPM24: In booming obesity field, Novo Nordisk is 'just getting going,' CEO says Source: fierce
read moreJPM24: BioMarin’s new CEO Hardy says top priority is expansion of dwarfism drug Voxzogo kdunleavy Wed, 01/10/2024 – 11:11 More: JPM24: BioMarin's new CEO Hardy says top priority is expansion of dwarfism drug Voxzogo Source: fierce
read moreAcelRx becomes Talphera, adopting new name to reflect pain pivot ntaylor Wed, 01/10/2024 – 09:47 More: AcelRx becomes Talphera, adopting new name to reflect pain pivot Source: fierce
read moreFDA rips MiMedx with warning letter for its placental collagen wound-care treatment jkeenan Wed, 01/10/2024 – 09:17 More: FDA rips MiMedx with warning letter for its placental collagen wound-care treatment Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals